ASTRAZENECA PLC - 31 Dec 2025 SCHEDULE 13G/A Report for Monopar Therapeutics Inc. Common Stock, $0.001 par value per share (MNPR)

Filing Manager
ASTRAZENECA PLC
Reporting Manager
AstraZeneca PLC
Security
Monopar Therapeutics Inc. Common Stock, $0.001 par value per share
Symbol
MNPR
Shares outstanding
6,700,859 shares
Disclosed Ownership
522,667 shares
Ownership
7.8%
Form type
SCHEDULE 13G/A
Filing time
06 Feb 2026, 09:54:43 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ASTRAZENECA PLC disclosed 7.8% ownership in Monopar Therapeutics Inc. Common Stock, $0.001 par value per share (MNPR) on 31 Dec 2025."

Quick Takeaways

  • ASTRAZENECA PLC filed SCHEDULE 13G/A for Monopar Therapeutics Inc. Common Stock, $0.001 par value per share (MNPR).
  • Disclosed ownership: 7.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Feb 2026, 09:54.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
AstraZeneca PLC 7.8% 522,667 522,667 0 /s/ Matthew Bowden Matthew Bowden / Company Secretary
Alexion Pharmaceuticals, Inc. 7.8% 522,667 522,667 0 /s/ Todd Spalding Todd Spalding / Secretary

Sponsored